http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018211114-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e66c6064d5c79b6bb366b921648204e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
filingDate 2018-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e14dfe79e0a127f103f340134fd83940
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c08d5bffd7941dfab9dbd886dcbd52e4
publicationDate 2018-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018211114-A1
titleOfInvention Anti-inflammatory high-purity oligosaccharides
abstract The present invention relates to a high-purity oligosaccharide for use as a drug and to a pharmaceutical composition which contains the high-purity oligosaccharide according to the invention.
priorityDate 2017-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017119660-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0183556-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226428549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9812710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226605252

Total number of triples: 45.